Literature DB >> 4978080

Scleroderma. 1. Clinical features, course of illness and response to treatment in 61 cases.

A J Barnett, D A Coventry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4978080     DOI： 10.5694/j.1326-5377.1969.tb49844.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  10 in total

1.  Hepatocyte giant mitochondria: an almost constant lesion in systemic scleroderma.

Authors:  G Feldmann; M Maurice; J M Husson; J N Fiessinger; J P Camilleri; J P Benhamou; E Housset
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-06-23

2.  New ACR EULAR guidelines for systemic sclerosis classification.

Authors:  Sindhu R Johnson
Journal:  Curr Rheumatol Rep       Date:  2015-05       Impact factor: 4.592

Review 3.  How useful are serum autoantibodies in the diagnosis and prognosis of systemic sclerosis?

Authors:  O Meyer
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

4.  Anti-Scl-70 antibodies detected by immunoblotting in progressive systemic sclerosis: specificity and clinical correlations.

Authors:  A Aeschlimann; O Meyer; P Bourgeois; T Haim; N Belmatoug; E Palazzo; M F Kahn
Journal:  Ann Rheum Dis       Date:  1989-12       Impact factor: 19.103

Review 5.  The diagnosis and classification of scleroderma (systemic sclerosis).

Authors:  A J Barnett; M Miller; G O Littlejohn
Journal:  Postgrad Med J       Date:  1988-02       Impact factor: 2.401

6.  Antinuclear antibodies in patients with scleroderma (systemic sclerosis) and in their blood relatives and spouses.

Authors:  A J Barnett; L J McNeilage
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

7.  Membranoproliferative glomerulonephritis in systemic sclerosis of childhood.

Authors:  R Waldherr; H P Seelig; B Klare; J Abigt
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-08-22

8.  Long-term follow-up study of 164 patients with definite systemic sclerosis: classification considerations.

Authors:  M Vayssairat; N Baudot; N Abuaf; C Johanet
Journal:  Clin Rheumatol       Date:  1992-09       Impact factor: 2.980

9.  Ocular involvement in scleroderma.

Authors:  R H West; A J Barnett
Journal:  Br J Ophthalmol       Date:  1979-12       Impact factor: 4.638

10.  Are There Clinical Differences in Limited Systemic Sclerosis according to Extension of Skin Involvement?

Authors:  Marina Scolnik; Luis J Catoggio; Eliana Lancioni; Mirtha R Sabelli; Carla M Saucedo; Josefina Marin; Enrique R Soriano
Journal:  Int J Rheumatol       Date:  2014-11-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.